The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation
Abstract
Osteocytes are the most abundant cells in bone and are ideally located to influence bone turnover through their syncytial relationship with surface bone cells. Osteocyte‐derived signals have remained largely enigmatic, but it was recently reported that human osteocytes secrete sclerostin, an inhibitor of bone formation. Absent sclerostin protein results in the high bone mass clinical disorder sclerosteosis. Here we report that within adult iliac bone, newly embedded osteocytes were negative for sclerostin staining but became positive at or after primary mineralization. The majority of mature osteocytes in mineralized cortical and cancellous bone was positive for sclerostin with diffuse staining along dendrites in the osteocyte canaliculi. These findings provide for the first time in vivo evidence to support the concept that osteocytes secrete sclerostin after they become embedded in a mineralized matrix to limit further bone formation by osteoblasts. Sclerostin did not appear to influence the formation of osteocytes. We propose that sclerostin production by osteocytes may regulate the linear extent of formation and the induction or maintenance of a lining cell phenotype on bone surfaces. In doing so, sclerostin may act as a key inhibitory signal governing skeletal microarchitecture.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, osteocyte markers including dentine matrix protein 1 (DMP1) and sclerostin are highly expressed [8, 62–64].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [63]
In the citing paper
“Sclerostin is a product of the SOST gene and is known to be a negative regulator of bone formation, by antagonizing in osteoblasts the actions of Lrp5, a key receptor of the Wnt/β-catenin signaling pathway [63].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [63]
In the citing paper
“Another endogenous Wnt antagonist secreted almost exclusively by osteocytes, sclerostin, decreases bone formation by repressing osteoblast differentiation and proliferation [[92], [93], [94]].”
From Emerging role of liver-bone axis in osteoporosis (2024) · cites this paper as [92]
Citations
Cites
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G., Sutherland, M. K., Geoghegan, J. C., Yu, C., Hayes, T., Skonier, J. E., Shpektor, D., Jonas, M., Kovacevich, B. R., Staehling‐Hampton, K., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,114
Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011
Self-citationvan Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L. J. A., de Wilt, E., Karperien, M., Hamersma, H. A., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 893
Self-citationVerborgt, O., Gibson, G. J., & Schaffler, M. B. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.60 · Cited by 731
Dobnig, H., & Turner, R. T. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628403 · Cited by 614
Periosteum: biology, regulation, and response to osteoporosis therapies
Allen, M. R., Hock, J. M., & Burr, D. B. (2004) · Bone · doi:10.1016/j.bone.2004.07.014 · Cited by 449
The Death of Osteocytes via Apoptosis Accompanies Estrogen Withdrawal in Human Bone
Tomkinson, A., REEVE, J., Shaw, R. W., & Noble, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4200 · Cited by 417
Self-citation
Research works printed but not linked: 2
- Warmington K., 2004, Sclerostin antagonism in adult rodents, via monoclonal antibody mediated blockade, increases bone mineral density and implicates sclerostin as a key regulator of bone mass during adulthood (Abstract), J. Back Musculoskeletal. Rehabil., 19, S56
- 10.1210/jc.82.9.3128 · DOI
Cited by
Sorted by citations
Items 401–500 of 966
The osteocyte: the underestimated conductor of the bone orchestra
BONUCCI, E. (2009) · RENDICONTI LINCEI · doi:10.1007/s12210-009-0051-y · Cited by 33
The role of osteocytes during experimental orthodontic tooth movement: A review
Murshid, S. A. (2016) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2016.09.001 · Cited by 33
The Epidemiology and Pathogenesis of Osteoporosis
Rosen, C. J. (2014) · Europe PMC (PubMed Central) · Cited by 32
Javaheri, B., Carriero, A., Wood, M., de Souza, R. L., Lee, P. D., Shefelbine, S. J., & Pitsillides, A. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-25084-6 · Cited by 33
Naqvi, S. M., Pérez, J. A. P., Kumar, V., Verbruggen, A. S. K., & McNamara, L. M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00601 · Cited by 35
Holdsworth, G., Staley, J. R., Hall, P., van Koeverden, I. D., Vangjeli, C., Okoye, R., Boyce, R. W., Turk, J. R., Armstrong, M., Wolfreys, A., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4287 · Cited by 32
Low Bone Mineral Density in Hemophiliacs
Gebetsberger, J., Schirmer, M., Wurzer, W. J., & Streif, W. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.794456 · Cited by 32
CXCR 4 antagonism attenuates load‐induced periosteal bone formation in mice
Leucht, P., Temiyasathit, S., Russell, A. L., Arguello, J. F., Jacobs, C. R., Helms, J. A., & Castillo, A. B. (2013) · Journal of Orthopaedic Research® · doi:10.1002/jor.22440 · Cited by 32
Emerging role of liver-bone axis in osteoporosis
Gao, H., Peng, X., Li, N., Gou, L., Xu, T., Wang, Y., Qin, J., Liang, H., Ma, P., Li, S., et al. (2024) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.07.008 · Cited by 36
Paradoxical Sost gene expression response to mechanical unloading in metaphyseal bone
Macias, B. R., Aspenberg, P., & Agholme, F. (2013) · Bone · doi:10.1016/j.bone.2013.01.018 · Cited by 32
Villaseñor, A., Aedo-Martín, D., Obeso, D., Erjavec, I., Rodríguez‐Coira, J., Buendía, I., Ardura, J. A., Barbas, C., & Gortázar, A. R. (2019) · Scientific Reports · doi:10.1038/s41598-018-38154-6 · Cited by 32
Lau, P., Vico, L., & Rittweger, J. (2022) · Biomedicines · doi:10.3390/biomedicines10020342 · Cited by 32
Boschert, V., van Dinther, M., Weidauer, S. E., van Pee, K., Muth, E.-M., ten Dijke, P., & Mueller, T. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081710 · Cited by 33
Fontalis, A., Kenanidis, E. I., Kotronias, R. A., Papachristou, A., Anagnostis, P. G., Potoupnis, M. E., & Tsiridis, E. E. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1594772 · Cited by 31
Osteocytes and mechanical loading: The Wnt connection
Bullock, W. A., Pavalko, F. M., & Robling, A. G. (2019) · Orthodontics and Craniofacial Research · doi:10.1111/ocr.12282 · Cited by 31
Role of bone morphogenetic proteins and their antagonists in healing of bone fracture
Brian Dean, D. (2009) · Frontiers in bioscience · doi:10.2741/3419 · Cited by 30
Novel approaches to the treatment of osteoporosis
Appelman‐Dijkstra, N. M., & Papapoulos, S. E. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.07.003 · Cited by 31
Self-citationMMP-13 is one of the critical mediators of the effect of HDAC4 deletion on the skeleton
Nakatani, T., Chen, T., & Partridge, N. C. (2016) · Bone · doi:10.1016/j.bone.2016.06.010 · Cited by 29
Kim, J.-H., Kim, A. R., Choi, Y. H., Kim, A., Sohn, Y., Woo, G., Cha, J., Bak, E., & Yoo, Y. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1438-2 · Cited by 29
Characterization of a novel murine Sost ERT2 Cre model targeting osteocytes
Maurel, D. B., Matsumoto, T., Vallejo, J. A., Johnson, M. L., Dallas, S. L., Kitase, Y., Brotto, M. A. P., Wacker, M., Harris, M. A., Harris, S. E., et al. (2019) · Bone Research · doi:10.1038/s41413-018-0037-4 · Cited by 29
Connexin 43 Channels in Osteocytes Regulate Bone Responses to Mechanical Unloading
Zhao, D., Liu, R., Li, G., Chen, M., Shang, P., Yang, H., Jiang, J. X., & Xu, H. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00299 · Cited by 29
Sclerostin expression in trabecular bone is downregulated by osteoclasts
Koide, M., Yamashita, T., Murakami, K., Uehara, S., Nakamura, K., Nakamura, M., Matsushita, M., Ara, T., Yasuda, H., Penninger, J. M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70817-1 · Cited by 32
A novel model of in vitro osteocytogenesis induced by retinoic acid treatment
Mattinzoli, D., Messa, P., Corbelli, A., Ikehata, M., Zennaro, C., Armelloni, S., Li, M., Giardino, L., & Rastaldi, M. (2012) · European Cells and Materials · doi:10.22203/ecm.v024a29 · Cited by 29
Miyagawa, K., Kozai, Y., Ito, Y., Furuhama, T., Naruse, K., Nonaka, K., Nagai, Y., Yamato, H., Kashima, I., Ohya, K., et al. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0241-9 · Cited by 30
Targeting the Wnt signaling pathway to augment bone formation
Shahnazari, M., Yao, W., Corr, M., & Lane, N. E. (2008) · Current Osteoporosis Reports · doi:10.1007/s11914-008-0025-5 · Cited by 29
Sclerostin deficiency modifies the development of CKD-MBD in mice
Kaesler, N., Verhulst, A., Maré, A. D., Deck, A., Behets, G. J. S., Hyusein, A., Evenepoel, P., Floege, J., Marx, N., Babler, A., et al. (2017) · Bone · doi:10.1016/j.bone.2017.11.015 · Cited by 29
Delgado‐Calle, J., Arozamena, J., Pérez-López, J., Bolado‐Carrancio, A., Sañudo, C., Agudo, G., de la Vega, R., Alonso, M. A., Rodríguez-Rey, J. C., & Riancho, J. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.02.002 · Cited by 28
Agholme, F., Isaksson, H., Li, X., Ke, H. Z., & Aspenberg, P. (2011) · Acta Orthopaedica · doi:10.3109/17453674.2011.625539 · Cited by 29
Comparison of black, green and rooibos tea on osteoblast activity
Nash, L. A., & Ward, W. E. (2016) · Food & Function · doi:10.1039/c5fo01222h · Cited by 28
Sclerostin Deficiency Promotes Reparative Dentinogenesis
Collignon, A.-M., Amri, N., Lesieur, J., Sadoine, J., Ribes, S., Ménashi, S., Simon, S. R. J., Berdal, A., Rochefort, G. Y., Chaussain, C., et al. (2017) · Journal of Dental Research · doi:10.1177/0022034517698104 · Cited by 28
Kurgan, N., McKee, K. T., Calleja, M., Josse, A. R., & Klentrou, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.531926 · Cited by 31
Mabey, T., Honsawek, S., Tanavalee, A., Wilairatana, V., Yuktanandana, P., Saetan, N., & Zhan, D. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.03.011 · Cited by 28
Minireview: Targeting the Wnt/-Catenin Pathway to Regulate Bone Formation in the Adult Skeleton
Baron, R., & Rawadi, G. (2007) · Cited by 28
Macaulay, T. R., Siamwala, J. H., Hargens, A. R., & Macias, B. R. (2017) · Bone Reports · doi:10.1016/j.bonr.2017.08.004 · Cited by 28
Curtis, K. J., Coughlin, T. R., Mason, D. E., Boerckel, J. D., & Niebur, G. L. (2017) · Bone · doi:10.1016/j.bone.2017.11.007 · Cited by 26
PTH and PTHR1 in osteocytes. New insights into old partners
Yavropoulou, M. P., Michopoulos, A., & Yovos, J. G. (2017) · HORMONES · doi:10.14310/horm.2002.1730 · Cited by 30
Roumpou, A., Palermo, A., Tournis, S., Hasenmajer, V., Pasieka, J. L., Kaltsas, G., Isidori, A. M., & Kassi, E. N. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf010 · Cited by 35
Wang, L., Yang, H., Huang, J., Pei, S., Wang, L., Feng, J. Q., Jing, D., Zhao, H., Kronenberg, H. M., Moore, D. C., et al. (2021) · Bone Research · doi:10.1038/s41413-020-00129-7 · Cited by 28
Toward Mechanical Systems Biology in Bone
Trüssel, A. J., Müller, R., & Webster, D. J. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-012-0594-4 · Cited by 27
Advancing our understanding of osteocyte cell biology
Guo, D., & Bonewald, L. F. (2009) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x09341484 · Cited by 27
Rictor is required for optimal bone accrual in response to anti-sclerostin therapy in the mouse
Sun, W., Shi, Y., Lee, W., Lee, S.-Y., & Long, F. (2016) · Bone · doi:10.1016/j.bone.2016.01.013 · Cited by 27
Kashii, M., Matuso, Y., Sugiura, T., Fujimori, T., Nagamoto, Y., Makino, T., Kaito, T., Ebina, K., Iwasaki, M., & Yoshikawa, H. (2015) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-015-0671-5 · Cited by 27
The role of cells and signal pathways in subchondral bone in osteoarthritis
Luo, P., Yuan, Q., Yang, M., Wan, X., & Xu, P. (2023) · Bone and Joint Research · doi:10.1302/2046-3758.129.bjr-2023-0081.r1 · Cited by 28
Role of Klotho in bone and implication for CKD
Komaba, H., & Lanske, B. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000423 · Cited by 26
Treatment of Osteoporosis: Unmet Needs and Emerging Solutions
Langdahl, B. L., & Andersen, J. D. (2018) · Journal of Bone Metabolism · doi:10.11005/jbm.2018.25.3.133 · Cited by 25
Gingival crevicular fluid levels of sclerostin in chronic periodontitis and healthy subjects
Esfahrood, Z. R., Yadegari, Z., veysari, S. K., & Kadkhodazadeh, M. (2018) · 대한구강악안면외과학회지 · doi:10.5125/jkaoms.2018.44.6.289 · Cited by 26
Chen, K., Zhao, J., Qiu, M., Zhang, L., Yang, K., Chang, L., Jia, P., Jin, Q., Deng, L., & Li, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.721561 · Cited by 26
Regulation of sclerostin by the SIRT1 stabilization pathway in osteocytes
Kim, J., Yang, Y.-S., Xie, J., Lee, O., Kim, J., Hong, J., Boldyreff, B., Filhol, O., Chun, H., Greenblatt, M. B., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00952-x · Cited by 26
Targeting osteocytes vs osteoblasts
Kitase, Y., & Prideaux, M. (2023) · Bone · doi:10.1016/j.bone.2023.116724 · Cited by 30
Shinoda, Y., Kawaguchi, H., Higashikawa, A., Hirata, M., Miura, T., Saito, T., Nakamura, K., Chung, U., & Ogata, N. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22454 · Cited by 26
Barbe, M. F., Massicotte, V. S., Assari, S., Monroy, M. A., Frara, N. A., Harris, M. Y., Amin, M., King, T. E., Cruz, G. E., & Popoff, S. N. (2018) · Bone · doi:10.1016/j.bone.2018.02.014 · Cited by 27
Klein‐Nulend, J., & Bonewald, L. F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00028-8 · Cited by 26
Emerging drugs for postmenopausal osteoporosis
Lewiecki, E. M. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210902766813 · Cited by 26
Physiologically based mathematical model of transduction of mechanobiological signals by osteocytes
Hambli, R., & Rieger, R. (2011) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-011-0294-2 · Cited by 27
The Cells of Bone and Their Interactions
Ansari, N., & Sims, N. A. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_343 · Cited by 29
Nisio, A. D., Toni, L. D., Speltra, E., Rocca, M. S., Taglialavoro, G., Ferlin, A., & Foresta, C. (2015) · Endocrinology · doi:10.1210/en.2015-1244 · Cited by 25
Induction of an osteocyte-like phenotype by fibroblast growth factor-2
Gupta, R. R., Yoo, D. J., HEBERT, C. A., Niger, C., & Stains, J. P. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.011 · Cited by 25
Kawazoe, M., Kaneko, K., Shikano, K., Kusunoki, N., Nanki, T., & Kawai, S. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3689-3 · Cited by 25
Musculoskeletal Health in the Context of Spinal Cord Injury
Clark, J., & Findlay, D. M. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0400-1 · Cited by 28
Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease
McDonald, M. M., & Delgado‐Calle, J. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0403-y · Cited by 25
Computational model of the dual action of PTH — Application to a rat model of osteoporosis
Trichilo, S., Scheiner, S., Forwood, M. R., Cooper, D. M. L., & Pivonka, P. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.04.020 · Cited by 25
Current Status of Bone-Forming Therapies for the Management of Osteoporosis
Sølling, A. S., Harsløf, T., & Langdahl, B. L. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00675-8 · Cited by 25
Korn, P., Krämer, I., Schlottig, F., Tödtmann, N., Eckelt, U., Bürki, A., Ferguson, S. J., Kautz, A. R., Schnabelrauch, M., Range, U., et al. (2019) · European Cells and Materials · doi:10.22203/ecm.v037a20 · Cited by 25
Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
Thiele, S., Hannemann, A., Winzer, M., Baschant, U., Weidner, H., Nauck, M. A., Thakker, R. V., Bornhäuser, M., Hofbauer, L. C., & Rauner, M. (2019) · Endocrine Connections · doi:10.1530/ec-19-0104 · Cited by 25
Emerging therapeutic targets for osteoporosis
Gennari, L., Merlotti, D., Falchetti, A., Eller-Vainicher, C., Cosso, R., & Chiodini, I. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1726889 · Cited by 25
Role of Regulators of G Protein Signaling Proteins in Bone Physiology and Pathophysiology
Jules, J., Yang, S., Chen, W., & Li, Y. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.02.002 · Cited by 27
Sasakia, M., Hongo, H., Hasegawa, T., Suzuki, R., Liu, Z., de Freitas, P. H. L., Yamada, T., Oda, K., Yamamoto, T., Li, M., et al. (2012) · Oral Science International · doi:10.1016/s1348-8643(12)00009-2 · Cited by 24
Lessons from rare diseases of cartilage and bone
Gallagher, J. A., Ranganath, L. R., & BOYDE, A. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.04.002 · Cited by 24
Role of sclerostin in the pathogenesis of chronic kidney disease-mineral bone disorder
Asamiya, Y., Tsuchiya, K., & Nitta, K. (2016) · Renal Replacement Therapy · doi:10.1186/s41100-016-0024-4 · Cited by 24
Role of pannexin 1 channels in load‐induced skeletal response
Şeref-Ferlengez, Z., Urban-Maldonado, M. M., Sun, H. B., Schaffler, M. B., Suadicani, S. O., & Thi, M. M. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13914 · Cited by 26
Autoantibodies in Spondyloarthritis, Focusing on Anti-CD74 Antibodies
Liu, Y., Liao, X., & Shi, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00005 · Cited by 24
Osteocytes: Mechanosensors of Bone and Orchestrators of Mechanical Adaptation
Klein‐Nulend, J., & Bakker, A. D. (2007) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-008-9014-6 · Cited by 25
Jia, H., Ma, J. X., L., X., Yu, J. T., Feng, R., Xu, L. Y., Wang, J., Xing, D., Zhu, S., & Wang, Y. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2818-y · Cited by 26
Kırkpantur, A., Balci, M., Türkvatan, A., & Afşar, B. (2015) · Nefrología · doi:10.1016/j.nefro.2015.07.006 · Cited by 26
Bone Development and Remodeling
Maes, C., & Kronenberg, H. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00060-3 · Cited by 26
Wu, J., Ma, L., Wu, L., & Jin, Q. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6278 · Cited by 24
Bone and Inflammatory Responses to Training in Female Rowers over an Olympic Year
Kurgan, N., Logan-Sprenger, H. M., Falk, B., & Klentrou, P. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001640 · Cited by 24
Shalash, M. A. M., Rohoma, K. H., Kandil, N. S., Mohsen, M. A. A., & Taha, A. A. F. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.04.012 · Cited by 24
Metastases and multiple myeloma generate distinct transcriptional footprints in osteocytes in vivo
Eisenberger, S., Ackermann, K., Voggenreiter, G., Sültmann, H., Kasperk, C., & Pyerin, W. G. (2008) · The Journal of Pathology · doi:10.1002/path.2322 · Cited by 24
Hasegawa, T., Amizuka, N., Yamada, T., Liu, Z., Miyamoto, Y., Yamamoto, T., Sasaki, M., Hongo, H., Suzuki, R., de Freitas, P. H. L., et al. (2013) · Biomedical Research · doi:10.2220/biomedres.34.153 · Cited by 24
Boman, A., Kokkonen, H., Ärlestig, L., Berglin, E. H., & Rantapää‐Dahlqvist, S. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3570-4 · Cited by 24
Accelerated fracture healing with teriparatide
Borges, J. L. C., Freitas, A., & Bilezikian, J. P. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000200010 · Cited by 23
Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
Clarke, B. L. (2011) · Yearbook of Endocrinology · doi:10.1016/j.yend.2011.04.012 · Cited by 23
Schwestermann, J., Bešše, A., Driessen, C., & Bešše, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.899272 · Cited by 27
The Role of Sclerostin in the Pathophysiology of Sclerosing Bone Dysplasias
van Lierop, A. H., Hamdy, N. A. T., van Bezooijen, R. L., Löwik, C. W. G. M., & Papapoulos, S. E. (2011) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-011-9123-5 · Cited by 23
Self-citationImmunolocalization of MMP 2, 9 and 13 in prednisolone induced osteoporosis in mice.
Sun, B., Sun, J., Han, X., Liu, H., Li, J., Du, J., Feng, W., Liu, B., Cui, J., Guo, J., et al. (2016) · PubMed · doi:10.14670/hh-11-702 · Cited by 23
Treatment of Osteoporosis, with a Focus on 2 Monoclonal Antibodies
Chang, B., Quan, Q., Li, Y., Qiu, H., Jiang, P., & Gu, Y. (2018) · Medical Science Monitor · doi:10.12659/msm.912309 · Cited by 23
Sclerostin injection enhances orthodontic tooth movement in rats
Lu, W., Zhang, X., Firth, F., Mei, L., Yi, J., Gong, C., Li, H., Zheng, W., & Li, Y. (2018) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2018.12.011 · Cited by 24
Kubota, T., Michigami, T., & Ozono, K. (2010) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.19.49 · Cited by 24
The Response of wnt/ß-Catenin Signaling Pathway in Osteocytes Under Simulated Microgravity
Yang, X. Y., Sun, L., Liang, M., Wang, X.-N., & Fan, Y. (2015) · Microgravity Science and Technology · doi:10.1007/s12217-015-9439-8 · Cited by 22
Is there a role for bisphosphonates in vascular calcification in chronic kidney disease?
Hildebrand, S., & Cunningham, J. (2020) · Bone · doi:10.1016/j.bone.2020.115751 · Cited by 22
Regulatory Roles of Bone in Neurodegenerative Diseases
Yu, Z., Ling, Z., Lin, L., Zhao, J. X., Chen, X., Xu, P., & Zou, X. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.610581 · Cited by 22
Zhang, S., Bach-Gansmo, F. L., Xia, D., Besenbacher, F., Birkedal, H., & Dong, M. (2015) · Nano Research · doi:10.1007/s12274-015-0825-8 · Cited by 22
Kalousová, M., Sulková, S., Kuběna, A. A., Zakiyanov, O., Tesař, V., & Zima, T. (2019) · Physiological Research · doi:10.33549/physiolres.934034 · Cited by 22
Can structural damage be prevented in ankylosing spondylitis?
Sieper, J. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32832c668a · Cited by 22
Zuo, G., Zhang, L., Jin, Q., Kang, H., Jia, P., Chen, H., Shen, X., Guo, L., Zhou, H., Wang, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121266 · Cited by 22
A model of osteoblast–osteocyte kinetics in the development of secondary osteons in rabbits
Pazzaglia, U. E., Congiu, T., Franzetti, E., Marchese, M., Spagnuolo, F., Mascio, L. D., & Zarattini, G. (2012) · Journal of Anatomy · doi:10.1111/j.1469-7580.2012.01477.x · Cited by 22
Role of cortical bone in hip fracture
REEVE, J. (2017) · BoneKEy Reports · doi:10.1038/bonekey.2016.82 · Cited by 21
Self-citationHsu, C., Maddox, J., Block, G. A., Bartley, Y., & Yu, Z. (2022) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2050 · Cited by 21
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Atkins, G. J., Kogawa, M., Findlay, D. M., & Wijenayaka, A. R. (2011) · The Endocrine Society eBooks · doi:10.1210/endo-meetings.2011.part1.or3.or02-3 · Cited by 23
Metadata
- Authors
- Poole, K. E. S., Van Bezooijen, R. L., Loveridge, N., Hamersma, H., Papapoulos, S. E., Löwik, C. W., & Reeve, J.
- Affiliations
- University of Cambridge (GB)
- Department of Endocrinology and Metabolic Diseases Leiden University Medical Centre Leiden Netherlands
- South Africa
- Leiden University (NL)
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2005-08-25
- Volume
- 19
- Issue
- 13
- Pages
- 1842-1844
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1970864109
- Cited by
- 965
- References
- 34
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 32 · 2023: 39 · 2022: 38 · 2021: 45 · 2020: 74 · 2019: 63 · 2018: 55 · 2017: 53 · 2016: 66 · 2015: 67 · 2014: 55 · 2013: 62 · 2012: 63
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- National Osteoporosis Society
- European Commission (LSHM‐CT‐2003‐503020)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- sclerostin, osteocytes, bone formation inhibition, sclerosteosis, osteoblasts, bone mineralization, bone lining cells, bone turnover
- MeSH terms
- Aged, Alkaline Phosphatase, Antibodies, Monoclonal, Biopsy, Bone and Bones, Bone Development, Bone Diseases, Developmental, Bone Resorption, Cell Differentiation, Coloring Agents, Female, Genetic Markers, Humans, Image Processing, Computer-Assisted, Immunohistochemistry, Male, Microscopy, Fluorescence, Middle Aged, Models, Biological, Osteoblasts, Osteocytes, Osteogenesis, RNA, Messenger, Time Factors, Tolonium Chloride, Signal Transduction, Bone Remodeling, Bone Morphogenetic Proteins, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review